Amager Hospital, Denmark has entered an agreement with ViroGates for the use of suPARnostic® TurbiLatex in clinical routine practice for the triage and severity assessment of all acute clinical patients in the Emergency Room.

Meet us at DASEM 2019 - Årsmøde Dansk Selskab for Akutmedicin / Danish Society for Emergency Medicine on April 26-27 in Middelfart, Denmark.

ViroGates announces that the development and regulatory approval of the suPARnostic® TurbiLatex product for Roche Diagnostics cobas c500 and c700 series has been completed.

ViroGates announces that the development and regulatory approval of the suPARnostic® TurbiLatex product for Roche Diagnostics cobas c502 has been completed.